Ni Cheng

Title: Ni Cheng: Innovator in Immunology

Introduction

Ni Cheng is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of immunology through her innovative research and patent work. Her expertise lies in the modulation of inflammatory and immune responses, which has important implications for medical science.

Latest Patents

Ni Cheng holds a patent titled "Toll-like receptor agonists and antagonists and methods of use thereof." This patent focuses on compositions and methods for modulating inflammatory and immune responses by binding serum amyloid A (SAA) to Toll-like receptor 2 (TLR2) in various subjects, including humans and rodents. The research highlights the role of SAA in inducing neutrophilia through macrophage secretion of G-CSF, establishing a link between increased SAA concentration and TLR2-mediated inflammatory responses.

Career Highlights

Ni Cheng is affiliated with the University of Illinois, where she conducts her research. Her work has led to a deeper understanding of the mechanisms behind immune responses and inflammation, paving the way for potential therapeutic applications.

Collaborations

Ni Cheng collaborates with notable colleagues, including Richard D. Ye and Rong L. He. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.

Conclusion

Ni Cheng is a dedicated inventor whose work in immunology has the potential to impact medical treatments significantly. Her innovative research and patent contributions continue to advance the understanding of immune responses and inflammation.